Antitumor and proapoptotic effect of Abrus agglutinin derived peptide in Dalton's lymphoma tumor model.
Abrus agglutinin peptide fractions obtained from 10 kD molecular weight cut off membrane permeate (10 kMP), was shown to have selective antiproliferative activity on several tumor cell lines with induction of apoptosis through mitochondrial pathway. The present study was designed to evaluate acute general toxicity and in vivo therapeutic effectiveness of 10 kMPP in Dalton's lymphoma (DL) mice model. The acute toxicity like body weight, peripheral blood cell count, lympho-hematological and biochemical parameters remained unaffected with 1mg/kg body weight and lower of 10 kMPP. The in vivo antitumor study indicated that there were 27%, 58.5% and 84.5% reduction in DL cell survival in 100, 200 and 500 microg/kg body weight of 10 kMPP, respectively. Analysis of the growth inhibitory mechanism in DL cells revealed nuclear fragmentation and condensation with appearance of the sub G0/G1 peak is indicative of apoptosis. Further, the Western blotting showed apoptosis was mediated by reduction in ratio of Bcl-2 and Bax protein expression, and activation of caspase-3 through release of cytochrome-c in DL cells. Kaplan-Meier survival analysis showed an effective antitumor response (53 ILS%) with dose of 500 microg/kg body weight. Our result showed that the novel peptides present in Abrus agglutinin possess potent antitumor properties which need to be further explored.
Department of Biotechnology, Indian Institute of Technology, Kharagpur 721302, West Bengal, India.
Sujit K
SK
Bhutia
Sanjaya K
SK
Mallick
Swatilekha
S
Maiti
Tapas K
TK
Maiti
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D017209:Apoptosis / Q000187:drug effects*; D002467:Cell Nucleus / Q000187:drug effects / Q000378:metabolism; D049109:Cell Proliferation / Q000187:drug effects; D002470:Cell Survival / Q000187:drug effects; D004195:Disease Models, Animal; D018450:Disease Progression; D004354:Drug Screening Assays, Antitumor; D005260:Female; D005434:Flow Cytometry; D008223:Lymphoma / Q000473:pathology*; D051379:Mice; D008970:Molecular Weight; D010455:Peptides / Q000494:pharmacology*; D037121:Plant Lectins / Q000494:pharmacology*; D016019:Survival Analysis
D000970:Antineoplastic Agents; D010455:Peptides; D037121:Plant Lectins; C016940:abrus agglutinin